Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...
Patent
1977-04-06
1979-01-23
Thomas, Jr., James O.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant or stably-transformed bacterium encoding one or...
560 41, 260558P, 260559R, 2603453, 260327R, 424275, 424278, 424309, 424324, 562442, 562451, C07C 6344, A01N 0920
Patent
active
041361970
ABSTRACT:
An N-substituted carboxylic acid amide of the formula ##STR1## wherein A is a valency bond or an oxygen or sulphur atom or a methylene, ethylene, vinylene, ethyleneoxa or ethylenethia radical,
REFERENCES:
patent: 3536753 (1970-10-01), Gruenfeld et al.
patent: 3839433 (1974-10-01), Wasley
patent: 3940422 (1976-02-01), Harita et al.
patent: 4026896 (1977-05-01), Harita et al.
Bosies Elmar
Heerdt Ruth
Hubner Manfred
Kuhnle Hans
Schmidt Felix H.
Boehringer Mannheim GmbH
Reamer James H.
Thomas, Jr. James O.
LandOfFree
Hypoglycaemically and hypolipidaemically effective n-substituted does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hypoglycaemically and hypolipidaemically effective n-substituted, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hypoglycaemically and hypolipidaemically effective n-substituted will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2273529